1. Home
  2. ESI vs IBRX Comparison

ESI vs IBRX Comparison

Compare ESI & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Element Solutions Inc.

ESI

Element Solutions Inc.

N/A

Current Price

$39.22

Market Cap

9.2B

Sector

Industrials

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.92

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESI
IBRX
Founded
1922
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
7.5B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
ESI
IBRX
Price
$39.22
$7.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
7
Target Price
$35.56
$12.57
AVG Volume (30 Days)
4.2M
8.5M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
0.75%
N/A
EPS Growth
N/A
38.71
EPS
0.23
N/A
Revenue
$2,551,200,000.00
$113,288,000.00
Revenue This Year
$21.24
$88.59
Revenue Next Year
$7.34
$131.15
P/E Ratio
$168.74
N/A
Revenue Growth
3.84
668.31
52 Week Low
$22.86
$1.95
52 Week High
$49.25
$12.43

Technical Indicators

Market Signals
Indicator
ESI
IBRX
Relative Strength Index (RSI) 51.78 54.53
Support Level $38.39 $7.77
Resistance Level $39.19 $8.46
Average True Range (ATR) 1.18 0.36
MACD 0.39 0.08
Stochastic Oscillator 92.24 86.95

Price Performance

Historical Comparison
ESI
IBRX

About ESI Element Solutions Inc.

Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: